Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Factors affecting pleural fluid adenosine deaminase level and the implication on the diagnosis of tuberculous pleural effusion: a retrospective cohort study

Authors: Tunn Ren Tay, Augustine Tee

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Adenosine deaminase (ADA) is useful in the diagnosis of tuberculous pleural effusion (TPE). This study aims to determine the factors affecting pleural fluid ADA levels and to establish the optimal ADA levels for diagnosis of TPE for different age groups.

Methods

This was a retrospective study from January 2007 to October 2011. One hundred and sixty patients who had pleural fluid ADA performed for investigation of pleural effusion were analyzed. Variables examined included demographics, pleural fluid characteristics and peripheral blood counts. The ADA cut-offs according to age were selected using the receiver operating characteristic (ROC) curve.

Results

The mean pleural fluid ADA was significantly higher in the TPE group (100 ± 35 IU/L) compared to non TPE patients (30 ± 37 IU/L). There was significant correlation between pleural fluid ADA and age, pleural fluid protein, LDH, and fluid absolute lymphocyte count. The strongest correlation was seen with age (r = −0.621). For patients ≤ 55 years old the ROC for ADA had area under curve (AUC) of 0.887. A pleural fluid ADA of 72 IU/L had sensitivity of 95.1%, specificity of 87.5%, positive predictive value (PPV) of 95.1% and negative predictive value (NPV) of 87.5% for the diagnosis of TPE. For patients > 55 years old the AUC is 0.959. ADA of 26 IU/L had a sensitivity of 94.7%, specificity of 80.4%, PPV of 62% and NPV of 97.8%.

Conclusions

There is a significant negative correlation between pleural fluid ADA and age. For older patients, a lower ADA cut-off should be used to exclude TPE.
Appendix
Available only for authorised users
Literature
1.
go back to reference Light RW: Pleural Diseases. 2007, Philadelphia: Lippincott Williams & Wilkins, 5 Light RW: Pleural Diseases. 2007, Philadelphia: Lippincott Williams & Wilkins, 5
2.
go back to reference Sahn SA: Getting the most from pleural fluid analysis. Respirology. 2012, 17: 270-277. 10.1111/j.1440-1843.2011.02100.x.CrossRefPubMed Sahn SA: Getting the most from pleural fluid analysis. Respirology. 2012, 17: 270-277. 10.1111/j.1440-1843.2011.02100.x.CrossRefPubMed
3.
go back to reference Valdes L, Alvarez D, Valle JM, Pose A, v E: The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest. 1996, 109: 158-162. 10.1378/chest.109.1.158.CrossRefPubMed Valdes L, Alvarez D, Valle JM, Pose A, v E: The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest. 1996, 109: 158-162. 10.1378/chest.109.1.158.CrossRefPubMed
4.
go back to reference Liam CK, Lim KH, Wong CM: Causes of pleural exudates in a region with a high incidence of tuberculosis. Respirology. 2000, 5: 33-38. 10.1046/j.1440-1843.2000.00223.x.CrossRefPubMed Liam CK, Lim KH, Wong CM: Causes of pleural exudates in a region with a high incidence of tuberculosis. Respirology. 2000, 5: 33-38. 10.1046/j.1440-1843.2000.00223.x.CrossRefPubMed
5.
go back to reference Valdes L, Alvarez D, San José E, Penela P, Valle JM, García-Pazos JM, Suárez J, Pose A: Tuberculous pleurisy: study of 254 patients. Arch Intern Med. 1998, 158: 2017-2021. 10.1001/archinte.158.18.2017.CrossRefPubMed Valdes L, Alvarez D, San José E, Penela P, Valle JM, García-Pazos JM, Suárez J, Pose A: Tuberculous pleurisy: study of 254 patients. Arch Intern Med. 1998, 158: 2017-2021. 10.1001/archinte.158.18.2017.CrossRefPubMed
6.
go back to reference Valdes L, San José E, Alvarez D, et al: Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest. 1993, 103: 458-465. 10.1378/chest.103.2.458.CrossRefPubMed Valdes L, San José E, Alvarez D, et al: Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest. 1993, 103: 458-465. 10.1378/chest.103.2.458.CrossRefPubMed
7.
go back to reference Gopi A, Madhavan SM, Sharma SK, Sahn SA: Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007, 131: 880-889. 10.1378/chest.06-2063.CrossRefPubMed Gopi A, Madhavan SM, Sharma SK, Sahn SA: Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007, 131: 880-889. 10.1378/chest.06-2063.CrossRefPubMed
8.
go back to reference Baganha MF, Pego A, Lima MA, Gaspar EV, Cordeiro AR: Serum and pleural adenosine deaminase: correlations with lymphocytic populations. Chest. 1990, 97: 605-610. 10.1378/chest.97.3.605.CrossRefPubMed Baganha MF, Pego A, Lima MA, Gaspar EV, Cordeiro AR: Serum and pleural adenosine deaminase: correlations with lymphocytic populations. Chest. 1990, 97: 605-610. 10.1378/chest.97.3.605.CrossRefPubMed
9.
go back to reference Niwa Y, Kishimoto H, Shimokata K: Carcinomatous and tuberculous pleural effusions: comparison of tumour markers. Chest. 1985, 87: 351-355. 10.1378/chest.87.3.351.CrossRefPubMed Niwa Y, Kishimoto H, Shimokata K: Carcinomatous and tuberculous pleural effusions: comparison of tumour markers. Chest. 1985, 87: 351-355. 10.1378/chest.87.3.351.CrossRefPubMed
10.
go back to reference Riantawan P, Chaowalit P, Wongsangiem M, Rojanaraweewong P: Diagnostic value of pleural fluid adenosine deaminase in tuberculouspleuritis with reference to HIV coinfection and a Bayesian analysis. Chest. 1999, 116: 97-103. 10.1378/chest.116.1.97.CrossRefPubMed Riantawan P, Chaowalit P, Wongsangiem M, Rojanaraweewong P: Diagnostic value of pleural fluid adenosine deaminase in tuberculouspleuritis with reference to HIV coinfection and a Bayesian analysis. Chest. 1999, 116: 97-103. 10.1378/chest.116.1.97.CrossRefPubMed
11.
go back to reference Yeon KM, Kim CJ, Kim JS, Kim CH: Influence of age on the adenosine deaminase activity in patients with exudative pleural effusion. Tuberculosis Respir Dis. 2002, 53: 530-541.CrossRef Yeon KM, Kim CJ, Kim JS, Kim CH: Influence of age on the adenosine deaminase activity in patients with exudative pleural effusion. Tuberculosis Respir Dis. 2002, 53: 530-541.CrossRef
12.
go back to reference Valdes L, Alvarez D, San Jose E, Juanatey J, Pose A, Valle JM, Salgueiro M, Suarez J: Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis. Thorax. 1995, 50: 600-603. 10.1136/thx.50.6.600.CrossRefPubMedPubMedCentral Valdes L, Alvarez D, San Jose E, Juanatey J, Pose A, Valle JM, Salgueiro M, Suarez J: Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis. Thorax. 1995, 50: 600-603. 10.1136/thx.50.6.600.CrossRefPubMedPubMedCentral
13.
go back to reference Merino JM, Carpintero I, Alvarez T, Rodrigo J, Sanchez J, Coello JM: Tuberculous pleural effusion in children. Chest. 1998, 115: 26-30.CrossRef Merino JM, Carpintero I, Alvarez T, Rodrigo J, Sanchez J, Coello JM: Tuberculous pleural effusion in children. Chest. 1998, 115: 26-30.CrossRef
14.
go back to reference Lee YC, Rogers JT, Rodriguez RM, Miller KD, Light RW: Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest. 2001, 120: 356-361. 10.1378/chest.120.2.356.CrossRefPubMed Lee YC, Rogers JT, Rodriguez RM, Miller KD, Light RW: Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest. 2001, 120: 356-361. 10.1378/chest.120.2.356.CrossRefPubMed
15.
go back to reference Kashiwabara K, Okamoto T, Yamane H: When pleural potassium exceeds 5.0 mEq/L, high pleural adenosine deaminase levels do not necessarily indicate tuberculouspleuritis. Respirology. 2012, 17: 92-98. 10.1111/j.1440-1843.2011.02053.x.CrossRefPubMed Kashiwabara K, Okamoto T, Yamane H: When pleural potassium exceeds 5.0 mEq/L, high pleural adenosine deaminase levels do not necessarily indicate tuberculouspleuritis. Respirology. 2012, 17: 92-98. 10.1111/j.1440-1843.2011.02053.x.CrossRefPubMed
16.
go back to reference Baba K, Hoosen AA, Langeland N, Dyrhol-Riise A: Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculouspleuritis in patients with very low CD4 counts. PloseOne. 2008, 3: 1-5. Baba K, Hoosen AA, Langeland N, Dyrhol-Riise A: Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculouspleuritis in patients with very low CD4 counts. PloseOne. 2008, 3: 1-5.
17.
go back to reference Valdes L, San Jose E, Alvarez D, Valle JM: Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Resp J. 1996, 9: 747-751. 10.1183/09031936.96.09040747.CrossRef Valdes L, San Jose E, Alvarez D, Valle JM: Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Resp J. 1996, 9: 747-751. 10.1183/09031936.96.09040747.CrossRef
18.
Metadata
Title
Factors affecting pleural fluid adenosine deaminase level and the implication on the diagnosis of tuberculous pleural effusion: a retrospective cohort study
Authors
Tunn Ren Tay
Augustine Tee
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-546

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.